Ambeed.cn

首页 / / / / Niflumic Acid/氟尼酸

Niflumic Acid/氟尼酸 {[allProObj[0].p_purity_real_show]}

货号:A207771 同义名: 尼氟酸 / Actol; Nifluril

Niflumic Acid 是一种钙激活氯通道阻滞剂,具有抗炎和镇痛活性,适用于类风湿性关节炎及其他炎症性疾病的机制研究。

HazMat Fee +

There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.

Type HazMat fee for 500 gram (Estimated)
Excepted Quantity USD 0.00
Limited Quantity USD 15-60
Inaccessible (Haz class 6.1), Domestic USD 80+
Inaccessible (Haz class 6.1), International USD 150+
Accessible (Haz class 3, 4, 5 or 8), Domestic USD 100+
Accessible (Haz class 3, 4, 5 or 8), International USD 200+
Niflumic Acid/氟尼酸 化学结构 CAS号:4394-00-7
Niflumic Acid/氟尼酸 化学结构
CAS号:4394-00-7
Niflumic Acid/氟尼酸 3D分子结构
CAS号:4394-00-7
Niflumic Acid/氟尼酸 化学结构 CAS号:4394-00-7
Niflumic Acid/氟尼酸 3D分子结构 CAS号:4394-00-7
规格 价格 会员价 库存 数量
{[ item.pr_size ]}

{[ getRatePriceInt(item.pr_rmb, 1,1) ]}

{[ getRatePriceInt(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]}

{[ getRatePriceInt(item.pr_rmb, 1,1) ]}

{[ getRatePriceInt(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]}
{[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} {[ getRatePrice(item.pr_rmb_sale, 1,1,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate,item.mem_isinteger) ]} 现货 1周 咨询 - +
购物车0 收藏 询单

Niflumic Acid/氟尼酸 纯度/质量文件 产品仅供科研

货号:A207771 标准纯度: {[allProObj[0].p_purity_real_show]}
批次查询: 批次纯度:

全球学术期刊中引用的产品

Nature, 2025, 645, 793-800. Ambeed. [ A201204 , A444152 , A344107 , A952055 ]
Cell, 2025. Ambeed. [ A122167 ]
Science, 2025, 387(6729): eadp5637. Ambeed. [ A875019 ]
Sig. Transduct. Target. Ther., 2025, 10, 257. Ambeed. [ A104916 ]
Nat. Nanotechnol., 2025. Ambeed. [ A243018 , A1216705 , A522597 , A125401 , A1355641 ]
更多 >

Niflumic Acid/氟尼酸 生物活性

靶点
  • COX-2

  • GABA receptor

描述 Niflumic acid, a drug used for joint and muscular pain, affected Ca²⁺ signaling in different models. In MG63 cells, niflumic acid induced [Ca²⁺]i rises by evoking PLC-dependent (phospholipase C) Ca²⁺ release from the endoplasmic reticulum, and Ca²⁺ entry via PKC-sensitive (protein kinase C) store-operated Ca²⁺ entry. Niflumic acid also induced Ca²⁺-independent cell death[3]. Niflumic acid (10 and 30 mM) also inhibited the noradrenaline-induced increase in perfusion pressure and 30 mM niflumic acid reduced the pressor response to 1 nmol noradrenaline by 34 +/- 6%. The increases in perfusion elicited by 5-HT (0.3 and 3 nmol) were reduced by niflumic acid (10 and 30 mM) in a concentration-dependent manner and 30 mM niflumic acid inhibited responses to 0.3 and 3 nmol 5-HT by, respectively, 49 +/- 8% and 50 +/- 7%. Niflumic acid selectively reduces a component of noradrenaline- and 5-HT-induced pressor responses by inhibiting a mechanism which leads to the opening of voltage-gated calcium channels[4]. Niflumic acid restored core and associated symptoms of peripheral neuropathy by suppressing oxidative-nitrosative stress, inflammatory cytokines (TNF-α, IL-1β) and TRPV1 level in stavudine-induced neuropathic pain in rats. Pharmacological efficacy of niflumic acid (20 mg/kg) was equivalent to pregabalin (30 mg/kg) [5].

Niflumic Acid/氟尼酸 细胞实验

Cell Line
Concentration Treated Time Description References
Rat aortic smooth muscle cells 10 µM 10 min Niflumic acid did not inhibit contractions induced by KCl (up to 120 mM), which were completely blocked by nifedipine. Br J Pharmacol. 1996 Jun;118(4):1065-71
CHO cells 30, 100 µM 10 s Niflumic acid inhibited glycine-induced currents mediated by α3 glycine receptors, with higher blocking potency at positive membrane potentials. Front Mol Neurosci. 2017 May 16;10:125
CHO cells 10, 30, 100 µM 10 s Niflumic acid showed stronger inhibition of glycine-induced currents mediated by α2 glycine receptors, with pronounced voltage dependence. Front Mol Neurosci. 2017 May 16;10:125
CHO cells 30, 100, 300 µM 10 s Niflumic acid inhibited glycine-induced currents mediated by α1 glycine receptors in a voltage-dependent manner, with higher blocking potency at positive membrane potentials. Front Mol Neurosci. 2017 May 16;10:125
Rat skeletal muscle fibers 42 µM (IC50) 10–15 minutes Niflumic acid inhibits chloride conductance of rat skeletal muscle by directly inhibiting the CLC-1 channel and by increasing intracellular calcium. Br J Pharmacol. 2007 Jan;150(2):235-47
Hypoglossal motoneurons (HMs) in brainstem slices from mice 100 µM 1-3 minutes NFA inhibited the amplitude and frequency of glycinergic synaptic currents, with stronger inhibition in the neonatal group Front Mol Neurosci. 2018 Nov 13;11:416
Rat aortic smooth muscle cells 10 µM 15 min In Ca-free conditions, niflumic acid did not inhibit the transient contraction induced by 1 μM NA, indicating it does not reduce calcium release from intracellular stores or the sensitivity of the contractile apparatus to calcium. Br J Pharmacol. 1996 Jun;118(4):1065-71
Rat aortic smooth muscle cells 10 µM 15 min Niflumic acid inhibited contractions induced by brief application of 1 μM NA by 55%. Br J Pharmacol. 1996 Jun;118(4):1065-71
Rat mesenteric vascular bed smooth muscle cells 10 and 30 µM 15 minutes Niflumic acid inhibited noradrenaline- and 5-HT-induced pressor responses, with 30 μM niflumic acid reducing the pressor response to 1 nmol noradrenaline by 34±6%. Br J Pharmacol. 1997 Mar;120(5):813-8
Rat stomach fundus smooth muscle cells 1-30 µM 15 minutes Niflumic acid concentration-dependently inhibited 5-HT-induced contractions, reducing to 15.5±6.0% of control at 30 μM. Br J Pharmacol. 2000 Jun;130(3):678-84
Rat pulmonary artery smooth muscle cells 50 µM 2 minutes NFA significantly increased basal [Ca2+]i and attenuated the caffeine-induced increase in [Ca2+]i. Br J Pharmacol. 2003 Dec;140(8):1442-50
Xenopus oocytes 100 µM 2 to 5 min NFA increased Kv1.1 current amplitudes by enhancing the channel open probability, causing a hyperpolarizing shift in the voltage dependence of both channel opening and gating charge movement, slowing the OFF-gating current decay. Proc Natl Acad Sci U S A. 2023 Aug;120(31):e2207978120
HEK293 cells 50 µM 24 hours Niflumic acid (NFA) acted as a pharmacological chaperone, restoring chloride current density of A531V and V947E mutants to levels similar to WT without altering voltage dependence. Front Pharmacol. 2022 Aug 11;13:958196
Rat aortic smooth muscle cells 3 µM and 10 µM 30 min Niflumic acid reversibly and concentration-dependently inhibited noradrenaline (NA)-induced contractions, with 10 μM niflumic acid inhibiting the maximal contraction by 38%. Br J Pharmacol. 1996 Jun;118(4):1065-71
BALB/3T3 clone A31 (mouse normal fibroblasts) 158.8 ± 33.0 µM (IC50) 72 hours Evaluation of antiproliferative activity of niflumic acid alone, IC50 value was 158.8 ± 33.0 µM Int J Mol Sci. 2024 Oct 13;25(20):11015
A172 (glioblastoma) 143.2 ± 6.5 µM (IC50) 72 hours Evaluation of antiproliferative activity of niflumic acid alone, IC50 value was 143.2 ± 6.5 µM Int J Mol Sci. 2024 Oct 13;25(20):11015
MCC13 (Merkel cell cancer) 175.4 ± 6.9 µM (IC50) 72 hours Evaluation of antiproliferative activity of niflumic acid alone, IC50 value was 175.4 ± 6.9 µM Int J Mol Sci. 2024 Oct 13;25(20):11015
SK-MEL-3 (melanoma) 167.1 ± 4.4 µM (IC50) 72 hours Evaluation of antiproliferative activity of niflumic acid alone, IC50 value was 167.1 ± 4.4 µM Int J Mol Sci. 2024 Oct 13;25(20):11015
UM-SCC-17A (head and neck squamous carcinoma) 310.3 ± 32.6 µM (IC50) 72 hours Evaluation of antiproliferative activity of niflumic acid alone, IC50 value was 310.3 ± 32.6 µM Int J Mol Sci. 2024 Oct 13;25(20):11015
A-431 (epidermoid carcinoma) 153.3 ± 43.1 µM (IC50) 72 hours Evaluation of antiproliferative activity of niflumic acid alone, IC50 value was 153.3 ± 43.1 µM Int J Mol Sci. 2024 Oct 13;25(20):11015
5637 (urinary bladder carcinoma) 103.5 ± 17.1 µM (IC50) 72 hours Evaluation of antiproliferative activity of niflumic acid alone, IC50 value was 103.5 ± 17.1 µM Int J Mol Sci. 2024 Oct 13;25(20):11015

Niflumic Acid/氟尼酸 动物实验

Species
Animal Model
Administration Dosage Frequency Description References
Rat Isolated mesenteric vascular bed Perfusion 10 and 30 μM 15 minutes pre-exposure Niflumic acid selectively inhibited noradrenaline- and 5-HT-induced pressor responses but did not affect KCl-induced pressor responses. Br J Pharmacol. 1997 Mar;120(5):813-8
Mice Kv1.1V408A/+ mouse model Intraperitoneal injection 10 mg/kg Single administration NFA ameliorated the motor performance of Kv1.1V408A/+ mice, significantly reducing foot slips and missteps on both narrow beam and horizontal ladder tasks. Proc Natl Acad Sci U S A. 2023 Aug;120(31):e2207978120
Mice Kir6.2−/− mice Pancreas perfusion 100 µM Single administration Niflumic acid almost completely blocked cAMP-induced glucose-stimulated insulin secretion Diabetologia. 2009 May;52(5):863-72
Rats Chronic hypoxia model Lung perfusion 30 μM Single administration To evaluate the role of Cl? channels in NS1619-induced pulmonary vasodilation Lung. 2014 Oct;192(5):811-7
Zebrafish Zebrafish embryos Bath application 500 µM 30 minutes Niflumic acid treatment caused bilateral muscle contractions in response to tactile stimulation Sci Rep. 2020 Aug 19;10(1):13999
Sprague Dawley rats Steroid-induced Pneumocystis pneumonia model Intraperitoneal injection 6 mg/kg/day Once daily for 4 weeks NFA caused a significant decrease in total mucus, MUC5AC and mCLCA3 and also, in Pneumocystis-associated inflammation. Most relevant, NFA treatment improved survival at 8 weeks of steroids. Front Microbiol. 2019 Jul 5;10:1522

Niflumic Acid/氟尼酸 参考文献

[1]Gogelein H, Dahlem D, et al. Flufenamic acid, mefenamic acid and niflumic acid inhibit single nonselective cation channels in the rat exocrine pancreas. FEBS Lett. 1990 Jul 30;268(1):79-82.

[2]White MM, Aylwin M. Niflumic and flufenamic acids are potent reversible blockers of Ca2(+)-activated Cl- channels in Xenopus oocytes. Mol Pharmacol. 1990 May;37(5):720-4.

[3]Liao WC, Chou CT, Liang WZ, et al. Exploration of Niflumic Acid’s Action on Ca²⁺ Movement and Cell Viability in Human Osteosarcoma Cells. Chin J Physiol. 2018;61(6):341‐348

[4]Criddle DN, de Moura RS, Greenwood IA, Large WA. Inhibitory action of niflumic acid on noradrenaline- and 5-hydroxytryptamine-induced pressor responses in the isolated mesenteric vascular bed of the rat. Br J Pharmacol. 1997;120(5):813‐818

[5]Marwaha L, Bansal Y, Singh R, Saroj P, Sodhi RK, Kuhad A. Niflumic acid, a TRPV1 channel modulator, ameliorates stavudine-induced neuropathic pain. Inflammopharmacology. 2016;24(6):319‐334

Niflumic Acid/氟尼酸 实验方案

计算器
存储液制备 1mg 5mg 10mg

1 mM

5 mM

10 mM

3.54mL

0.71mL

0.35mL

17.72mL

3.54mL

1.77mL

35.43mL

7.09mL

3.54mL

Niflumic Acid/氟尼酸 技术信息

CAS号4394-00-7
分子式C13H9F3N2O2
分子量 282.22
SMILES Code C1=C(C(=NC=C1)NC2=CC(=CC=C2)C(F)(F)F)C(O)=O
MDL No. MFCD00010569
别名 尼氟酸 ;Actol; Nifluril; Niflumic Acid, Donalgin, Flunir, Niflactol, Niflugel, Nifluril; UP83; Donalgin
运输蓝冰
InChI Key JZFPYUNJRRFVQU-UHFFFAOYSA-N
Pubchem ID 4488
存储条件

In solvent -20°C: 3-6个月 -80°C: 12个月

Pure form Sealed in dry,2-8°C

溶解方案

DMSO: 105 mg/mL(372.05 mM),注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO

请根据您的动物给药指南选择适当的溶解方案。
以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂:
——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶
方案 一
方案 二
AmBeed 相关网站 AmBeed.cn AmBeed.com
AmBeed
关于我们
联系我们
资讯中心
网站地图
产品手册
  • 批次文件查询
  • 客户支持
    技术支持
    专业术语
    缩略词释义
    质量手册
    产品咨询
    计算器
    活动政策
    订购方法
    积分商城
    活动声明
    联系我们
    400-920-2911 sales@ambeed.cn tech@ambeed.cn
    AmBeed 只为有资质的科研机构、医药企业基于科学研究或药证申报的用途提供医药研发服务,不为任何个人或者非科研性质用途提供服务。